T2 Biosystems PE Ratio 2013-2024 | TTOO
Current and historical p/e ratio for T2 Biosystems (TTOO) from 2013 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. T2 Biosystems PE ratio as of November 29, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| T2 Biosystems PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-11-29 | 0.57 | 0.00 | |
| 2024-09-30 | 1.97 | $-3.32 | 0.00 |
| 2024-06-30 | 5.34 | $-6.77 | 0.00 |
| 2024-03-31 | 3.00 | $-14.11 | 0.00 |
| 2023-12-31 | 6.28 | $-143.45 | 0.00 |
| 2023-09-30 | 22.09 | $-143.45 | 0.00 |
| 2023-06-30 | 7.06 | $-435.00 | 0.00 |
| 2023-03-31 | 46.00 | $-927.00 | 0.00 |
| 2022-12-31 | 142.00 | $-1,295.00 | 0.00 |
| 2022-09-30 | 565.00 | $-1,645.00 | 0.00 |
| 2022-06-30 | 807.50 | $-1,750.00 | 0.00 |
| 2022-03-31 | 2620.50 | $-1,650.00 | 0.00 |
| 2021-12-31 | 2581.00 | $-1,500.00 | 0.00 |
| 2021-09-30 | 4576.00 | $-1,500.00 | 0.00 |
| 2021-06-30 | 5950.00 | $-1,500.00 | 0.00 |
| 2021-03-31 | 8100.00 | $-1,550.00 | 0.00 |
| 2020-12-31 | 6200.00 | $-2,300.00 | 0.00 |
| 2020-09-30 | 6800.00 | $-3,450.00 | 0.00 |
| 2020-06-30 | 6350.00 | $-4,600.00 | 0.00 |
| 2020-03-31 | 3247.50 | $-5,900.00 | 0.00 |
| 2019-12-31 | 5850.00 | $-6,500.00 | 0.00 |
| 2019-09-30 | 12500.00 | $-6,750.00 | 0.00 |
| 2019-06-30 | 8400.00 | $-6,450.00 | 0.00 |
| 2019-03-31 | 13150.00 | $-6,300.00 | 0.00 |
| 2018-12-31 | 15050.00 | $-6,400.00 | 0.00 |
| 2018-09-30 | 37250.00 | $-4,650.00 | 0.00 |
| 2018-06-30 | 38700.00 | $-5,650.00 | 0.00 |
| 2018-03-31 | 32450.00 | $-6,550.00 | 0.00 |
| 2017-12-31 | 20600.00 | $-7,150.00 | 0.00 |
| 2017-09-30 | 21000.00 | $-9,500.00 | 0.00 |
| 2017-06-30 | 16050.00 | $-9,800.00 | 0.00 |
| 2017-03-31 | 26300.00 | $-10,200.00 | 0.00 |
| 2016-12-31 | 26300.00 | $-10,550.00 | 0.00 |
| 2016-09-30 | 36200.00 | $-11,000.00 | 0.00 |
| 2016-06-30 | 39450.00 | $-11,300.00 | 0.00 |
| 2016-03-31 | 49300.00 | $-11,100.00 | 0.00 |
| 2015-12-31 | 54700.00 | $-11,000.00 | 0.00 |
| 2015-09-30 | 43800.00 | $-10,450.00 | 0.00 |
| 2015-06-30 | 81150.00 | $-11,150.00 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.012B | $0.007B |
| T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, or T2MR, that enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets. It operates primarily in the United States. T2 Biosystems, Inc. is headquartered in Lexington, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $202.584B | 24.71 |
| Intuitive Surgical (ISRG) | United States | $193.049B | 100.93 |
| Alcon (ALC) | Switzerland | $43.825B | 29.32 |
| Edwards Lifesciences (EW) | United States | $42.082B | 26.72 |
| IQVIA Holdings (IQV) | United States | $36.452B | 20.08 |
| IDEXX Laboratories (IDXX) | United States | $34.535B | 40.67 |
| DexCom (DXCM) | United States | $30.463B | 45.88 |
| Waters (WAT) | United States | $22.843B | 33.78 |
| STERIS (STE) | Ireland | $21.623B | 24.89 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.352B | 0.00 |
| Hologic (HOLX) | United States | $18.042B | 19.49 |
| Sysmex ADR (SSMXY) | Japan | $13.304B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.922B | 13.27 |
| Globus Medical (GMED) | United States | $11.657B | 29.52 |
| Penumbra (PEN) | United States | $9.369B | 91.77 |
| Masimo (MASI) | United States | $9.238B | 44.70 |
| Teleflex (TFX) | United States | $8.957B | 14.28 |
| Glaukos (GKOS) | United States | $7.920B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.988B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.713B | 26.71 |
| Veracyte (VCYT) | United States | $3.329B | 99.88 |
| Inari Medical (NARI) | United States | $3.040B | 0.00 |
| TransMedics (TMDX) | United States | $2.910B | 92.25 |
| LivaNova (LIVN) | United Kingdom | $2.851B | 16.46 |
| Nihon Kohden (NHNKY) | Japan | $2.276B | 17.29 |
| Elekta AB (EKTAY) | Sweden | $2.261B | 20.33 |
| Tandem Diabetes Care (TNDM) | United States | $2.012B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.897B | 9.91 |
| RxSight (RXST) | United States | $1.889B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.486B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.316B | 0.00 |
| Artivion (AORT) | United States | $1.237B | 82.00 |
| OPKO Health (OPK) | United States | $1.051B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.881B | 14.97 |
| Paragon 28 (FNA) | United States | $0.863B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.746B | 0.00 |
| IRadimed (IRMD) | United States | $0.683B | 36.94 |
| Mesa Laboratories (MLAB) | United States | $0.636B | 15.00 |
| OrthoPediatrics (KIDS) | United States | $0.629B | 0.00 |
| AxoGen (AXGN) | United States | $0.612B | 0.00 |
| SiBone (SIBN) | United States | $0.569B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.531B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.523B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.473B | 27.82 |
| Tactile Systems Technology (TCMD) | United States | $0.469B | 25.38 |
| Delcath Systems (DCTH) | United States | $0.380B | 0.00 |
| CVRx (CVRX) | United States | $0.372B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.341B | 0.00 |
| NeuroPace (NPCE) | United States | $0.316B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.282B | 0.00 |
| Inogen (INGN) | United States | $0.231B | 0.00 |
| Accuray (ARAY) | United States | $0.224B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.203B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.196B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
| Nevro (NVRO) | United States | $0.172B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.164B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.139B | 14.93 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| 908 Devices (MASS) | United States | $0.095B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.091B | 0.00 |
| LENSAR (LNSR) | United States | $0.087B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.083B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.079B | 0.00 |
| InspireMD (NSPR) | Israel | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.074B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.072B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.069B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.059B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.055B | 0.00 |
| Envoy Medical (COCH) | United States | $0.046B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.045B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.042B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.039B | 0.00 |
| Spectral AI (MDAI) | United States | $0.036B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| Neuronetics (STIM) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.016B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.015B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |